Agenda
September 25-26, 2009
New York, NY
| International Congress for Lung Cancer, and Head & Neck Cancer SEPTEMBER 25-26, 2009 – NEW YORK, NY Friday – September 25, 2009 |
||
| 7:00 AM | Continental Breakfast and Registrations | |
| 7:55 AM | Welcome and Introductions | Chandra P. Belani, MD |
| Keynote Lectures
Session Chair: Chandra P. Belani, MD |
||
| 8:00 AM | Non-Small-Cell Lung Cancer: State of the Art | Chandra P. Belani, MD |
| 8:30 AM | Small-Cell Lung Cancer: State of the Art | Afsin Dowlati, MD |
| 9:00 AM | New Systemic Therapies for the Treatment of Head & Neck Cancer | Corey Langer, MD |
| 9:30 AM | Combined Multimodality Therapy of Lung Cancer, and Head & Neck Cancer | Gregory Videtic, MD |
| 10:00 AM | Panel Discussion | |
| 10:20 AM | BREAK | |
| EGFR and VEGF Targeted Agents
Session Chair: Suresh Ramalingam, MD |
||
| 10:30 AM | Erlotinib: Present Status and Future Perspectives, Molecular Markers and Patient Selection | Vincent Miller, MD |
| 11:00 PM | Advanced and Metastatic Non?Small-Cell Lung Cancer: Implications of Bevacizumab | Suresh Ramalingam, MD |
| 11:30 AM | Other VEGF Targeted Agents and Multikinase Inhibitors in the Treatment of Lung Cancer | George Simon, MD |
| 12:00AM | Panel Discussion | |
| 12:20 AM | LUNCH | |
| International Forum
Session Chair: Chandra P. Belani, MD |
||
| 1:20 PM | Phase III Studies in the USA | Chandra Belani, MD |
| 1:50 PM | Treatment Strategies/Phase III Trials in Europe | Georgio Scagliotti, MD |
| 2:20 PM | Emerging Agents in Lung Cancer: A Look into the Future | TBD |
| 2:50 PM | Panel Discussion | |
| 3:00PM | Closing Remarks & Adjourn | Chandra P. Belani, MD |
| Saturday, September 26, 2009 | ||
| 7:00 AM | Continental Breakfast | |
| 7:55 AM | Opening Remarks | Chandra P. Belani, MD |
| Imaging, Diagnosis and Surgical Intervention
Session Chair: Suresh Ramalingam, MD |
||
| 8:00 AM | Adjuvant Therapy for Non?Small-Cell Lung Cancer: Consensus and Controversies | Harvey Pass, MD |
| 8:25 AM | Lung Cancer Imaging –PET Scanning | Jeremy Erasmus, MD |
| 8:50 AM | Panel Discussion | |
| 9:15 AM | BREAK | |
| Emerging Novel Agents and Supportive Care Issues
Session Chair: Chandra P. Belani, MD |
||
| 9:35 AM | Supportive Care Issues in Lung Cancer, and Head & Neck Cancer | Richard Gralla, MD |
| 9:50 AM | nab-Paclitaxel, Bortezomib and HDAC Inhibitors in the Treatment of Lung Cancer | Chandra P. Belani, MD |
| 10:15 AM | Emerging Novel Agents in Lung Cancer (TRAIL and mTOR Inhibitors, MEK Inhibitors, AKT Inhibitors and IGF-IR Antibodies, and Small Molecule Inhibitors, c-met Inhibitors | Fadlo Khuri MD |
| 10:40 AM | Panel Discussion | |
| 11:10 AM | Closing Remarks and Adjourn | Chandra P. Belani, MD |